BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25680254)

  • 1. Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia?
    Rijal RK; Nakhwa C; Sindal MD
    Nepal J Ophthalmol; 2014; 6(2):227-9. PubMed ID: 25680254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
    Bourla DH; Sarraf D; Schwartz SD
    Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
    Lee S; Kim HA; Yoon YH
    Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen maculopathy: The importance of screening and long follow-up.
    Zamorano Martín F; Rocha-de-Lossada C; Rachwani Anil R; Borroni D; Rodriguez Calvo de Mora M; España Contreras M
    J Fr Ophtalmol; 2020 Oct; 43(8):727-730. PubMed ID: 32620415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
    Shinkai A; Saito W; Hashimoto Y; Ishida S
    BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal imaging in persistent placoid maculopathy.
    Gendy MG; Fawzi AA; Wendel RT; Pieramici DJ; Miller JA; Jampol LM
    JAMA Ophthalmol; 2014 Jan; 132(1):38-49. PubMed ID: 24310266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy.
    Sridhar J; Shahlaee A; Rahimy E; Hong BK; Khan MA; Maguire JI; Dunn JP; Mehta S; Ho AC
    Am J Ophthalmol; 2015 Dec; 160(6):1259-1268.e2. PubMed ID: 26386158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy.
    Kelmenson AT; Brar VS; Murthy RK; Chalam KV
    Eur J Ophthalmol; 2010; 20(4):785-8. PubMed ID: 20099229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eyes have it! Tamoxifen maculopathy revisited: a case report.
    Nair AG; Das D; Goyal A; Gandhi RA
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):640-2. PubMed ID: 22731242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Berendschot TT; Staurenghi G; Holz FG; Scholl HP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1172-7. PubMed ID: 18326746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion.
    Rahimy E; Sarraf D; Dollin ML; Pitcher JD; Ho AC
    Am J Ophthalmol; 2014 Aug; 158(2):372-380.e1. PubMed ID: 24794089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triamcinolone-associated crystalline maculopathy.
    Sarraf D; Vyas N; Jain A; Bui A; Kertes PJ; Freund KB; Chan C
    Arch Ophthalmol; 2010 Jun; 128(6):685-90. PubMed ID: 20547944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
    Bommireddy T; Carrim ZI
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal imaging of torpedo maculopathy in a Chinese woman: a case report.
    Ding Y; Yao B; Ye H; Yu Y
    BMC Ophthalmol; 2019 Jul; 19(1):154. PubMed ID: 31324167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer.
    Ansari Astaneh MR; Shokoohi Rad S; Ghavami Shahri SH; Heidarzadeh HR
    J Oncol Pharm Pract; 2023 Mar; 29(2):489-492. PubMed ID: 35730198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
    Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
    Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.